First Time Loading...

Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 19.31 USD -0.87% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

VCYT Price Targets Summary
Veracyte Inc

Wall Street analysts forecast VCYT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VCYT is 31.45 USD with a low forecast of 21.21 USD and a high forecast of 38.85 USD.

VCYT Lowest Forecast
Wall Street Target
21.21 USD
10% Upside
VCYT Average Forecast
Wall Street Target
31.45 USD
63% Upside
VCYT Highest Forecast
Wall Street Target
38.85 USD
101% Upside
Lowest
Price Target
21.21 USD
10% Upside
Average
Price Target
31.45 USD
63% Upside
Highest
Price Target
38.85 USD
101% Upside
Veracyte Inc Competitors:
Price Targets
BIOA B
BioArctic AB
84% Upside
INBX
Inhibrx Inc
6% Upside
1672
Ascletis Pharma Inc
127% Upside
PANACEABIO
Panacea Biotec Ltd
52% Downside
BIOA B
BioArctic AB
84% Upside
INBX
Inhibrx Inc
6% Upside
1672
Ascletis Pharma Inc
127% Upside
PANACEABIO
Panacea Biotec Ltd
52% Downside
VIR
Vir Biotechnology Inc
300% Upside
MRUS
Merus NV
38% Upside
G
144510
GC Cell Corp
97% Upside
S
688180
Shanghai Junshi Biosciences Co Ltd
43% Upside

Revenue
Forecast

Revenue Estimate
Veracyte Inc

For the last 8 years the compound annual growth rate for Veracyte Inc's revenue is 28%. The projected CAGR for the next 3 years is 12%.

28%
Past Growth
12%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Veracyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Veracyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
VCYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
VCYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VCYT stock valuation using valuation multiples.
Wall Street Estimates
VCYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VCYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VCYT's stock price target?
Price Target
31.45 USD

According to Wall Street analysts, the average 1-year price target for VCYT is 31.45 USD with a low forecast of 21.21 USD and a high forecast of 38.85 USD.

What is Veracyte Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Veracyte Inc's revenue is 28%. The projected CAGR for the next 3 years is 12%.

ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.